Immunohistochemical detection of tryptase, Kit, and 2D7
| Diagnosis . | Serum tryptase (ng/mL) . | Immunoreactivity of AML cells in bone marrow sections . | ||
|---|---|---|---|---|
| Tryptase . | 2D7 . | Kit . | ||
| ALL | 8.9 | − | − | − |
| ALL | 4.0 | − | − | − |
| AML sek | 151 | + | + | +/− |
| AML M0 | 40.5 | + | + | + |
| AML M0 | 181.0 | +/− | + | − |
| AML M2 | 41.6 | + | + | + |
| AML M2 | 113.0 | + | + | + |
| AML M2 | 6.1 | − | − | − |
| AML M3 | 122.0 | + | + | + |
| AML M3 | 79.2 | +/− | + | +/− |
| AML M4 | 124.0 | + | + | + |
| AML M4 | 9.0 | − | − | − |
| AML M4 | 6.4 | − | − | − |
| AML M4 | 5.5 | − | − | − |
| AML M4 Eo | 77.0 | + | + | +/− |
| AML M4 Eo | 254.0 | +/− | − | +/− |
| AML M4 Eo | 881.0 | + | + | + |
| AML M5 | 45.0 | +/− | +/− | − |
| AML M5 | 5.4 | +/− | − | +/− |
| AML M5 | 13.2 | − | − | +/− |
| AML M6 | 5.1 | − | − | − |
| AML M6 | 8.9 | − | − | − |
| AML M6 | 1.9 | − | − | − |
| Diagnosis . | Serum tryptase (ng/mL) . | Immunoreactivity of AML cells in bone marrow sections . | ||
|---|---|---|---|---|
| Tryptase . | 2D7 . | Kit . | ||
| ALL | 8.9 | − | − | − |
| ALL | 4.0 | − | − | − |
| AML sek | 151 | + | + | +/− |
| AML M0 | 40.5 | + | + | + |
| AML M0 | 181.0 | +/− | + | − |
| AML M2 | 41.6 | + | + | + |
| AML M2 | 113.0 | + | + | + |
| AML M2 | 6.1 | − | − | − |
| AML M3 | 122.0 | + | + | + |
| AML M3 | 79.2 | +/− | + | +/− |
| AML M4 | 124.0 | + | + | + |
| AML M4 | 9.0 | − | − | − |
| AML M4 | 6.4 | − | − | − |
| AML M4 | 5.5 | − | − | − |
| AML M4 Eo | 77.0 | + | + | +/− |
| AML M4 Eo | 254.0 | +/− | − | +/− |
| AML M4 Eo | 881.0 | + | + | + |
| AML M5 | 45.0 | +/− | +/− | − |
| AML M5 | 5.4 | +/− | − | +/− |
| AML M5 | 13.2 | − | − | +/− |
| AML M6 | 5.1 | − | − | − |
| AML M6 | 8.9 | − | − | − |
| AML M6 | 1.9 | − | − | − |
AML indicates acute myeloid leukemia; ALL, acute lymphoid leukemia.